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ABSTRACT 
We examine firms’ propensity to adapt their R&D collaboration portfolio by establishing new 
types of R&D collaboration with different kinds of partners (suppliers, customers, 
competitors and universities & public research institutions). We argue that existing R&D 
collaboration with one of the two value chain partners (suppliers or customers) is associated 
with the formation of new R&D collaboration with the other value chain partner to ensure 
temporal alignment in innovation within the value chain. In contrast, issues related to 
governance and unintended knowledge spillovers suggest that ‘horizontal’ R&D 
collaboration with competitors only spurs R&D collaboration with other partner types if such 
competitor R&D collaboration has been discontinued earlier (‘delayed temporal alignment’). 
We posit that persistent prior R&D collaboration with institutional partners is an antecedent 
to the establishment of new R&D collaboration with industrial partners, and that 
discontinuation of a particular type of R&D collaboration is likely to lead to a restart of such 
R&D collaborative effort. Strong prior innovative performance is expected to increase the 
probability that firms establish R&D collaborations with new partner types, except for R&D 
collaboration with competitors, since the most innovative firms may fear leakage of 
proprietary knowledge to rivals. We find broad support for these predictions in a large panel 
of Spanish innovating firms (2004-2011). Our findings highlight that it is not just the 
configuration of R&D collaborations with existing partner types that predicts tie formation 
with new partner types, but also the intertemporal pattern of prior R&D collaboration and 
managerial discretion provided by past innovation success. 
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INTRODUCTION 
For firms in technology-intensive industries, external R&D collaboration for 
innovation has become a pervasive phenomenon. R&D collaboration for innovation offers a 
number of substantive benefits, such as the possibility for mutual knowledge sharing, 
combining complementary skills with partners, scale economies in research, as well as the 
sharing of costs and risks (Ahuja, 2000). A large body of literature has shown that R&D 
collaboration can contribute to different performance outcomes such as innovation (e.g. 
Rothaermel and Deeds, 2004; Gilsing et al., 2008; Srivastana and Gnyawali, 2011), patenting 
(Gittelman and Kogut, 2003), organizational growth or failure (e.g. Mitsuhashi and Greve, 
2009) and manufacturing procurement efficiency (Gulati & Sytch, 2007). A related literature 
has considered alliance portfolios - as the aggregate of all alliances of a focal firm –  with a 
particular interest in portfolio diversity and its performance consequences (Rothaermel and 
Deeds, 2004; Faems et al., 2005; Heimeriks et al. 2009; Parmigiani and Rivera - Santos, 
2011; Wuyts et al., 2012; Lahiri and Narayanan, 2013; Jiang et al., 2010; Hashai et al., 2015). 
This is in line with the dominant, yet static, view in most of the R&D collaboration literature 
that emphasizes the stable value flowing from interfirm networks and R&D collaboration 
portfolios (Wassmer, 2010; Tasselli et al., 2015; Jiang, Tao, and Santoro, 2010; Hashai et al., 
2015).  
However, as several success stories on R&D collaboration for innovation have 
demonstrated, such as Procter and Gamble’s connect and develop program, IBM’s emerging 
business areas or Lego’s open innovation strategy, companies regularly adapt their portfolio 
of R&D collaborations in order to secure future competitiveness. This resonates with an 
emerging view in the literature that to ensure that R&D collaboration for innovation remains 
beneficial, firms need to adapt and renew their portfolio of partnerships on an ongoing basis 
(Powell et al., 1996; Ahuja et al., 2012). In particular, in technology-intensive environments, 
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rapid technological change may render existing knowledge and skills obsolete, implying that 
current R&D collaborations lose their value, and demanding adaptation of the R&D 
collaboration portfolio (Koka et al., 2006).  
Despite its importance, we still have only a limited understanding of how firms adapt 
their R&D collaboration portfolio, and what the drivers of such adaptations are. The more 
widely studied outcome effects of a firms’ R&D collaboration portfolios remain only 
partially understood if we lack an appreciation of how portfolios are created and get adapted 
before giving rise to such outcomes in the first place (Ahuja et al., 2012; Tatarinowitz et al., 
2016). The few studies on this topic have been theoretical (e.g. Koza and Lewin, 1998; Koka 
et al., 2006) or qualitative in nature (e.g. Lavie and Singh, 2012), and share a common 
emphasis on studying the evolution of an alliance portfolio under influence of, or in response 
to, contingencies and/or changes in a firm´s industry environment. While these studies have 
yielded some insightful characterizations of how R&D collaboration portfolios evolve, they 
have examined the evolution of alliance portfolios by emphasizing how exogenous changes 
in the environment affect portfolio change. 
In this paper, we aim to develop an agency-oriented understanding by considering the 
decisions to enter into new R&D collaborations and therewith adapt the R&D collaboration 
portfolio as a function of dynamic patterns of prior collaborations. Our focus is on a firm´s 
portfolio of R&D collaboration types, where we distinguish between customers and suppliers 
(vertical R&D collaboration), competitors (horizontal R&D collaboration) and research 
institutions and universities (institutional R&D collaboration).1 We take a strategic 
perspective and move beyond the level of R&D collaborations with individual partner firms, 
                                                 
1 We note that R&D collaboration with universities & public research insititutes has also been referred 
to as ‘upstream’ R&D collaboration (Bercovitz and Feldman, 2007; Rothaermel  and Deeds, 2004). In 
the current study we reserve the term ‘upstream’ for firms that are situated upstream from the focal 
firm in the value chain: suppliers.  
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to R&D collaboration decisions and portfolios at the level of collaboration types.     
  Conceptualizing R&D portfolios through the lens of different partner types is 
relevant, as R&D collaboration with different partner types gives rise to a potential for 
recombination that may spur the creation of innovations (Tidd et al., 2015; Faems et al., 
2005; Duysters and Lokshin, 2011; Nieto and Santamaria, 2007; Belderbos et al., 2004). To 
realize this recombination potential, a firm’s standing R&D collaborations may imply a 
sequence of R&D collaborative activities where R&D collaboration with one partner type, 
e.g. a university or a competitor, may lead to subsequent establishment of R&D 
collaborations with other partner types, e.g. suppliers or customers. Hence, the adaptation of a 
firm´s portfolio of R&D collaborations with different partner types is likely to have 
antecedents in prior patterns of R&D collaboration. This calls for a dynamic and integrative 
approach to analyze the establishment of new R&D collaboration types and therewith the 
adaptation of R&D portfolios – the approach that we take in this study.  
Studying decisions to collaborate and adapt R&D portfolios in an integrated manner is 
important as there is, as we will argue and show, strong heterogeneity in how existing 
collaborations with different partner types influence the formation of R&D collaboration with 
new partner types. We argue that distinct patterns of relationships between the dynamics of 
prior R&D collaboration (recently established, persistently pursued, or recently discontinued 
prior R&D collaboration) and the establishment of R&D collaboration with new partner types 
are likely to occur. This is because recombinatory search and accomplishing complementarity 
in R&D collaboration requires temporal alignment of R&D collaborations. Hence, standing 
R&D collaborations with a specific partner type predict subsequent R&D collaboration 
formation with another type, or the re-establishment of R&D collaboration with the same 
partner type. We posit that salient differences can be expected in this regard between 
institutional (universities & research institutes), vertical (buyer and supplier), and horizontal 
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(competitor) R&D collaboration. More specifically, we expect important benefits of inter-
temporal alignment in R&D collaboration with the two vertical chain partners (customers and 
suppliers) due to coordination advantages, and between university R&D collaboration and 
R&D collaboration with industry partners at large due to knowledge complementarities. In 
contrast, temporal alignment between existing R&D collaborations with competitors and new 
R&D collaborations with other partner types may lead to undesirable knowledge spillovers, 
creating a different dynamic and leading to delayed adaptation of the R&D collaboration 
portfolio through the establishment of R&D collaboration with new partner types. 
As a second antecedent of adaptation of the R&D collaboration portfolio, we consider 
a firm’s prior innovation performance. Whereas the literature has demonstrated that R&D 
collaboration contributes to innovation performance (Ahuja, 2000b; Gilsing et al., 2008), how 
such performance affects a firm’s propensity to engage in future R&D collaboration has 
remained underexposed (Phelps et al., 2012). While one may expect a positive 
interrelationship between prior performance and the formation of R&D collaborations 
because firms become more attractive as R&D collaboration partners in case of past 
innovation success, successful firms may at the same time find it less necessary to engage in 
R&D collaboration as they have demonstrated strong internal innovation capabilities (Ahuja, 
2000a; Phelps et al., 2012). Furthermore, firms with a strong innovation performance may 
fear that R&D collaboration could lead to involuntary knowledge dissipation to partner firms, 
which may hurt their innovation performance in the future. We argue that these 
considerations get different weights depending on the type of partner the firm seeks to 
establish R&D collaborations with, with major differences between competitor R&D 
collaboration and R&D collaborations with other partner types.  
 Empirically, we draw on panel data consisting of a large sample of Spanish 
innovating firms (2004-2011) and estimate multivariate probit models of the yearly formation 
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of R&D collaborations with a new partner type. We note one limitation and caveat up-front: 
our data do not pertain to R&D collaborations with individual partners, but to the start, 
cessation or continuation of R&D collaboration with different partner types. Hence, our 
theory and analysis focus on the broader strategic rationale for the dynamics of R&D 
collaboration patterns and remain agnostic of the absolute number of R&D collaborations 
with individual partners of each type.  
 
THEORY AND HYPOTHESES 
 Internal sources of technology development are often inadequate to cope with the 
increasing environmental complexity and speed of technological change (Barney, 1991; 
Mahoney and Pandian, 1992; Peteraf, 1993). Firms therefore rely on R&D collaborations 
with partners to access external sources of knowledge that may account for a substantial share 
of complementary inputs necessary for the development of successful innovations 
(Chesbrough et al., 2014; Fey and Birkinshaw, 2005). Recent studies have considered 
potential complementarities of different alliance types that serve different purposes, such as 
alliances for shaping environments, adapting environments or stabilizing environments 
(Hoffman, 2007), alliances for complementarity and/or compatibility (Mistsuhasi and Greve, 
2009), and alliance (networks) for exploration or exploitation (Koza and Lewin, 1998; 
Rothaermel and Deeds, 2006; Colombo et al., 2006; Gilsing and Nooteboom, 2006).  
  Diversity in partner types can bring innovation performance benefits if different partner 
types complement the focal firm’s resources and capabilities (Duysters and Lokshin, 2011; 
Faems et al., 2005; Nieto and Santamaria, 2007; Belderbos et al., 2004). The potential 
advantages of combining R&D collaboration with different partner types suggest that firms’ 
existing R&D collaboration portfolios can be an important antecedent of new R&D 
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collaborative tie formation (e.g. Lavie et al. 2011), as reaping the benefits of complementarity 
is likely to require temporal alignment between R&D collaborations.  
Most of the literature has focused on R&D collaborations with different individual 
partners - ‘with whom’ to ally - while ignoring differences among partner types. A number of 
prior studies focused on a specific type of R&D collaboration, such as horizontal R&D 
collaboration with competitors (Ahuja, 2000), vertical R&D collaboration between customers 
and suppliers (Gulati & Sytch, 2007), or R&D collaboration with universities (Gittelman and 
Kogut, 2003; Bercovitz and Feldman, 2007). Rothermael and Deeds (2004) is closest to our 
study in their focus on how one type of alliances (specifically exploration alliances with a 
focus on R&D and drug discovery) systematically predicts the formation of another type of 
alliances (exploitation alliances) - a relationship that is mediated by the number of products in 
development. However, neither of these prior studies systematically considered relationships 
between horizontal, vertical and institutional collaboration (Parmigiani and Rivera-Santos, 
2011). To address this issue, we examine the dynamic interrelationship between R&D 
collaborations with such different partner types, and do so across manufacturing industries 
rather than for a specific industry such as the biopharmaceutical industry (e.g. Rothaermel & 
Deeds, 2004).  
 Below we develop hypotheses focusing on such dynamic interrelationships. More 
specifically, we will examine the following three antecedents of the formation of R&D 
collaboration with a new partner type: 1) the role of recent, persistent, and prior discontinued 
R&D collaboration with other partner types (temporal alignment in R&D collaboration across 
partner types), 2) discontinued R&D collaboration as an antecedent of the re-establishment of 
R&D collaboration with that same partner type, and 3) prior innovative performance as an 
antecedent of the formation of R&D collaboration with a new partner type. Considering these 
antecedents helps to develop a better understanding of how firms’ R&D collaboration 
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portfolio diversity is created in a dynamic context. This portfolio development will carry 
consequences for firm performance, which in turn may affect the propensity to form new 
R&D collaborative ties (Ahuja, 2000a). In order to account for this recursive process, it is 
important to consider how a firm’s prior innovation performance affects its propensity to 
adapt its portfolio of R&D collaboration types. Table 1 illustrates the focus of our theory 
development and hypotheses: the independent variables and their predicted effects on R&D 
collaboration formation with a new partner type.  
 
INSERT TABLE 1 
 
New vertical R&D collaboration spanning the value chain 
 There are several reasons why R&D collaboration with one partner type can be an 
antecedent of the formation of new R&D collaborative R&D ties with other partner types. 
These reasons relate to potential synergies such as complementary skills of the different 
partner types as well as coordination advantages in product and process development. This 
implies that the probability of forming R&D collaborative R&D ties with a new partner type 
depends on the partner types with which the firm already collaborates. The specific temporal 
pattern of prior R&D collaboration with a partner type (recently formed, persistent, or 
discontinued) is expected affect this relationship. 
 There are compelling arguments to expect a particularly strong relationship between 
supplier and customer R&D collaboration (Belderbos et al., 2012). Vertical R&D 
collaboration with suppliers or customers implies the bridging of two value chain activities. 
By its nature, a value chain entails a highly systemic division of labor where changes in one 
value chain activity may have far-reaching implications for adjacent value chain activity – 
upstream and/or downstream. As a consequence, new product innovations or process 
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improvements need to be well coordinated in order to mitigate risks of (major) 
inconsistencies across two or more value steps and to ensure their timely commercialization 
and/or implementation (Diez-Vial, 2007; Littler and Leverick, 1995). Vertical R&D 
collaboration may also facilitate the reduction or elimination of operational inefficiencies 
along a value chain such as, for example, those resulting from ‘bullwhip’ effects due to 
demand variability (Metters, 1997; Lee et al., 1997; Gulati & Sytch, 2007). R&D 
collaboration with both types of chain partners enables firms to speedily commercialize new 
product innovations and to accomplish process improvements in both an efficient and 
effective way (Choi and Hartely, 1996; Fisher, 1997; Childerhouse et al., 2002; Rosenzweig 
et al., 2003). The operations management literature has suggested that it is this continuous 
engagement in vertical, value chain spanning, collaboration with suppliers and customers that 
achieves superior performance (Narasimhan and Jayaram, 1998; Vickery et al., 2003; 
Frohlich and Westbork, 2001; Rosenzweig et al., 2003; Roy and Whelan, 1992).  
Accomplishing these performance objectives induces a need for firms to act in tune 
and suggests the need for a temporal alignment in R&D collaboration with suppliers and 
customers. This temporal alignment may be accomplished in both directions, i.e. aligning 
existing supplier R&D collaboration with customer R&D collaboration, and vice versa. To 
the extent that R&D collaboration with suppliers is aimed at the creation of new innovations, 
it introduces a need for a focal firm to test the effects of market introduction with customers. 
Introducing innovations can be risky or costly for customers as it may require adaptations to 
their existing routines and practices (Christensen and Bower, 1996). R&D collaboration with 
a focal firm may be effective for customers since it will allow them to test and experiment 
with a new innovation before deciding to adopt it (Von Hippel, 1988; Tidd et al., 2015). 
Hence, current R&D collaboration with suppliers may naturally lead a focal firm to augment 
its R&D collaboration portfolio by starting R&D collaboration with customers.  
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Customer R&D collaboration in turn may provide new insights for further fine-tuning 
and improving the innovation, or in case of R&D collaboration with lead-users it may 
provide fresh ideas for new, future innovations (Von Hippel, 1988). Both situations will 
induce a need to initiate R&D collaboration with suppliers to develop these ideas further into 
improved or novel innovations. In general, innovations in the vertical R&D collaboration 
process benefit from a relatively speedy and well-coordinated process that requires R&D 
collaboration with suppliers and with customers. This implies that such R&D collaborations 
with suppliers and customers are preferably not pursued in isolation. If a firm engages in 
active (persistent or recent) R&D collaboration with one type of partner, the formation of 
R&D collaboration with the other partner type is likely to follow.  
In addition to the effectiveness of innovation in the value chain, there also is a 
resource scarcity logic that reinforces the need for temporal alignment between customer and 
supplier R&D collaboration. Firms face resource constraints that will limit the resources they 
can allocate to external R&D collaboration activities (Heimeriks et al., 2009). R&D 
collaboration with one partner type, e.g. suppliers, can consume ample resources and 
managerial attention, which will limit the room for simultaneous R&D collaboration with 
another partner type, e.g. customers. As a consequence, resource constraints can reinforce the 
need for consecutive supplier and customer R&D collaboration to coordinate vertical R&D 
collaboration along the value chain.  
The above arguments suggests a symmetric pattern in which existing R&D 
collaboration with suppliers (customers) will increase the propensity of firms to adapt the 
R&D collaboration portfolio by starting R&D collaboration with customers (suppliers). Since 
firms are expected to seek temporal alignment between existing R&D collaborations and the 
establishment of new R&D collaborations while alignment cannot be obtained if firms have 
previously discontinued their R&D collaboration with suppliers or customers, alignment is 
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not likely to be a consideration for previously discontinued collaborative R&D ties with 
customers, or suppliers. This leads to the following hypotheses: 
 
Hypothesis 1a: Existing (recently established and persistent) R&D collaboration with 
customers, rather than prior discontinued R&D collaboration with customers, are positively 
associated with a firm's propensity to augment its portfolio of R&D collaboration types by 
newly establishing R&D collaboration with suppliers.   
 
Hypothesis 1b: Existing (recently established and persistent) R&D collaboration with 
suppliers, rather than prior discontinued R&D collaboration with suppliers, is positively 
associated with a firm's propensity to augment its portfolio of R&D collaboration types by 
newly establishing R&D collaboration with customers.   
 
Prior (discontinued) R&D collaboration with competitors and the establishment of new 
R&D collaborations with other partner types 
 We argue that the influence of prior R&D collaboration with horizontal partners 
(competitors) on the establishment of R&D collaboration with new partner types shows a 
pattern that contrasts with that of vertical R&D collaboration. Whereas vertical R&D 
collaboration is generally considered to be well suited for enhancing existing competences 
and optimizing an established value chain (Brown and Eisenhardt, 1995), horizontal R&D 
collaborations are generally considered to be better suited for the creation of new, state-of-
the-art technology (Tidd et al., 2015). Horizontal R&D collaboration tends to focus on pre-
competitive development of far-from-market technology with wide(r) application potential 
(Teece, 1980; Hagedoorn, 2002; Belderbos et al., 2012; Tether, 2002). This may form the 
basis for a focal firm’s future competitive advantage in non-core domains, securing 
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continuity in the long term. Prior studies on the performance effects of R&D collaboration 
with different partner types have confirmed that R&D collaboration with competitors is often 
most effective for the generation of new-to-the-market products, while vertical R&D 
collaboration with suppliers and customers tend to impact on productivity growth, product 
and process improvements (Belderbos et al., 2004; Faems et. al., 2005).  
 Horizontal technology-based R&D collaboration may provide firms with access to 
scarce, external expertise on promising new technologies, and may allow for the exchange of 
knowledge between partners that stimulate learning and facilitate its further recombination 
(Ahuja, 2000b). Such recombinatory efforts may lead to the creation of technologies with a 
high novelty and value, which may induce R&D collaboration with other partner types in two 
different ways. First, discovery of new technology can induce a quest for further exploration 
and deepening of the new domain that leads to institutional R&D collaboration with 
universities & research institutes (Baba et al., 2009). Second, firms are likely to embark on 
exploitation efforts aimed at the commercialization and/or implementation of the newly 
created technology, which may involve vertical R&D collaboration with suppliers and/or 
customers (Choi and Hartely, 1996; Fisher, 1997; Childerhouse et al., 2002; Rosenzweig et 
al., 2003; Tidd et al., 2015).  
 R&D collaboration with competitors and the potentially associated new-to-the market 
technology and innovations also carries particular risks when following up on this in R&D 
collaborations with other partner types. Due to comparable knowledge bases and 
competences, competitors may have a greater capacity for absorption and appropriation of 
each other’s core knowledge and expertise, which eases the (undesirable) flow of spillovers 
and creates a temptation for free-ridership (Park and Russo, 1996; Gilsing and Nooteboom, 
2006). This implies that engagement in both horizontal and vertical R&D collaboration 
increases the likelihood that knowledge developed with customers, suppliers and/or 
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universities & research institutes, spills over to horizontal partners, conform the idea of 
indirect ties (Ahuja, 2000b) and second-hand brokerage (Burt, 2004). Since horizontal 
partners are likely to figure as a firm’s competitors in downstream markets, such knowledge 
spillovers may directly erode its competitive advantage (Ahuja, 2000a). In particular, if R&D 
collaboration is in the focal firm’s core domains, this may severely damage its 
competitiveness and threaten its future profitability.  
 Thus, although from an innovation perspective the potential complementarity between 
competitor R&D collaboration and R&D collaboration with other partner types is attractive, a 
governance perspective on R&D collaboration suggests important risks and drawbacks of 
close temporal alignment between horizontal and vertical R&D collaboration. We argue that 
these perspectives can be reconciled through delayed alignment. The governance risks are 
foremost an issue if the two types of R&D collaboration overlap in time, such that the focal 
firm connects competitors and vertical or institutional partners. At the same time, positive 
effects from an innovation perspective and reaping the benefits of complementarity may still 
be possible by combining horizontal with vertical or institutional R&D collaboration in a 
more consecutive manner. This suggests that discovery and development of next-generation 
technology with competitors may induce delayed institutional R&D collaboration with 
universities & research institutes for further deepening and search, or induce later vertical 
R&D collaboration with customers and suppliers in view of implementation and 
commercialization needs.  
 Overall, these arguments suggest that if horizontal R&D collaboration precedes 
institutional R&D collaboration with universities & public research institutes or precedes 
vertical R&D collaboration with suppliers and customers, governance risks related to 
overlapping R&D collaborations can be reduced, without sacrificing the combinatory 
benefits. Hence, the probability that a firm adds vertical and institutional R&D collaboration 
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to its R&D collaboration portfolio is expected to be higher if the firm has engaged in 
horizontal R&D collaboration, but only with a sufficient lag – i.e. when R&D collaboration 
with competitors has been prior discontinued. This leads to the following hypothesis:  
 
Hypothesis 2: Prior discontinued R&D collaboration with competitors, rather than existing 
R&D collaboration with competitors, is positively associated with a firm's propensity to 
augment its portfolio of R&D collaboration types by newly establishing R&D collaboration 
with other partner types.  
 
Existing institutional R&D collaboration and the establishment of R&D collaboration 
with other partner types  
 Universities & public research institutes generally are a key source of new, state-of-the-
art knowledge (Cockburn and Henderson, 1998; Zucker, et al., 2002; Bercowitz and 
Feldman, 2007; Cassiman et al., 2009). Knowledge as developed in universities is of a more 
generic nature, tends to be further away from commercialization, and typically contributes to 
the generation of new ideas for industrial R&D. Universities can also play a key role in 
contributing to the completion of existing R&D projects and technical problem solving in 
manufacturing processes (Cohen et al., 2002). In addition, R&D collaboration with 
universities in general, and with prestigious universities in particular, may elevate a firm’s 
status (Gregorio and Shane, 2004), increasing its attractiveness to other firms as a R&D 
collaboration partner. Here it is important that the firm is perceived as a reliable and stable 
partner and engages in such R&D collaboration persistently.  
 Although new scientific knowledge gets disseminated through publications, an 
important part of it is non-codified and can only be exchanged through close interaction 
between individuals within teams of university and firm scientists (Zucker et al. 2002; 
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Cassiman et al., 2009). This tacit and complex nature of scientific knowledge induces a need 
for longer term relationships with universities in order to get more deeply involved in, and 
familiar with, scientific research and the institutional norms governing knowledge creation at 
universities. Persistent R&D collaboration with universities can enable firms to better 
understand advances in fundamental research and evaluate its quality and usefulness. If a firm 
collaborates with universities & public research institutes on a persistent basis, it will be able 
to develop a deeper understanding of the fundamental principles of key phenomena under 
study, increasing the likelihood of the discovery of novel causal relationships that may result 
from such R&D collaboration (Bercowitz and Feldman, 2007). Prior research suggests that 
effective R&D collaboration with universities can subsequently allow firms to apply 
scientific insights to their applied R&D projects, but this process requires endurance and time 
before it enhances R&D productivity (Cockburn and Henderson, 1998; Zucker et al., 2002).  
 The more generic nature of knowledge  developed in R&D collaboration with 
universities and its potential for generating new ideas and enhancing applied research helps 
firms to assess which trajectories in applied research may probably become dead-ends and 
which will be the most promising opportunities (Fleming and Sorenson, 2004). This creates 
incentives for firms for subsequent R&D collaboration with different industrial partners to 
exploit such opportunities (Segarra-Blasco and Arauzi-Carod, 2008). Knowledge generated 
in R&D collaboration with universities may bring new insights that may open up entire new 
markets or market segments (Tether, 2002; Monjon and Waelbroeck, 2003; Leiponen, 2001; 
Veugelers and Cassiman, 2005) and may bring knowledge and new ideas for both process 
and product innovations (Monjon and Waelbroeck, 2003; Belderbos et al., 2004; Faems et al., 
2005). Capabilities acquired during persistent R&D collaboration with universities will aid 
firms in the effective selection and focus of those R&D collaborations with customers, 
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suppliers, or competitors in the commercialization of new technologies and the 
implementation of improved or new processes (Arranz and Arroyabe, 2008). 
 These arguments suggest that firms with prior persistent engagement in R&D 
collaboration with universities & research institutes have both the incentives and 
opportunities to start R&D collaboration with new industrial partner types. This leads to the 
following hypothesis: 
 
Hypothesis 3. Persistent involvement in R&D collaboration with universities & research 
institutes is positively associated with a firm’s propensity to augment its portfolio of R&D 
collaboration types by newly establishing R&D collaboration with industrial partners 
(suppliers, customers, competitors).  
 
Discontinued R&D collaboration and the propensity to renew R&D collaboration with 
the same partner type 
 Prior research on the dynamics of R&D collaboration has focused primarily on alliance 
termination, but less so on the propensity to restart R&D collaboration. Unsuccessful R&D 
collaborations are a frequent feature of inter-firm R&D collaboration and unsuccessful R&D 
collaboration rates of 30-50% are common findings in the literature (e.g. Bleeke and Ernst, 
1991; Harrigan, 1988; Killing, 1988; Lokshin et al., 2011). This while persistent R&D 
collaboration is likely to provide the strongest benefits in terms of innovation success (e.g. 
Belderbos et al., 2004). 
 Although the termination of R&D collaboration is not always the result of 
malfunctioning of the R&D collaboration but may also signal the completion of the R&D 
collaborative project when goals have been accomplished, the evidence suggests that 
discontinued R&D collaboration often implies that R&D collaborative efforts have met with 
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coordination problems (Lhuillery and Pfister, 2009). R&D collaboration implies the 
coordination of activities between two independent organizations that may share a need for 
resource exchange but will also differ in a number of ways. To the extent that partners differ 
substantially in terms of core activities, organizational culture, strategic aims and/or what 
they aim to achieve through R&D collaboration, coordination becomes difficult and R&D 
collaboration failure is more likely (Parkhe, 1993). Therefore, common problems are the 
pursuit of self-interest at the expense of the partner (Gulati, 1995), power imbalances 
between partners due to asymmetry in resource quality (Kogut, 1989), and technological 
uncertainty leading to unexpected outcomes that may be incongruent with the original 
purpose of the R&D collaboration. These problems can occur in R&D collaboration with 
each partner type. 
Notwithstanding these general reasons why individual R&D collaboration may fail, the 
general benefits of R&D collaboration with different partner types remain of strategic 
significance for innovating firms. Key benefits of R&D collaboration with any partner type 
are the sharing of costs and risks of R&D, access to unique and novel expertise regarding 
new technology and/or markets as well as the potential for resource complementarity that 
yields opportunities for recombination (Hagedoorn, 1993; Ahuja, 2000a).  
Hence, if a given individual R&D collaboration with a specific partner type fails 
because the specific firm or institution is no longer the best match or willing to continue, and 
this leads to the discontinuation of R&D collaboration with that partner type, innovation 
needs will request a tying up to a new individual partner of the same type to address the same 
strategic need. It follows that discontinued R&D collaboration with a type of partner is likely 
to lead to a subsequent restarting of R&D collaboration with that same type of partner. We 
hypothesize: 
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Hypothesis 4: Prior discontinued R&D collaboration with a partner type is positively 
associated with a firm’s propensity to augment its portfolio of R&D collaboration types 
again, by re-establishing R&D collaboration with that partner type. 
 
Past innovative success and the propensity to start new R&D collaborations: horizontal 
partners vs. other partner types 
 While R&D collaboration is often crucial for innovation success (Hagedoorn 1993; 
2002; Duysters and Lokshin, 2011; Rowley et al., 2000), innovation success in turn may spur 
further R&D collaboration. Firms that have established themselves as highly innovative will 
be considered as technologically capable and desirable as R&D collaboration partners (Stuart 
et al., 1999). Ahuja (2000a) argues that the propensity to establish  R&D collaborations is 
determined by both ‘inducements’ and ‘opportunities’, with differences in such firm-specific 
inducements and opportunities accounting for the uneven participation in inter-firm (R&D) 
collaborations. Successfully innovating firms may have greater opportunities to engage in 
R&D collaboration and are more attractive partners for joint technology development with 
suppliers, customers, competitors or universities. On the other hand, by participating in inter-
firm R&D collaboration, the more successful innovative firms face a danger of involuntary 
dissipation of their knowledge, which can lead to a weakening of their competitive advantage 
(Mitchell and Singh, 1992; Littler and Leverick, 1995; Molina-Morales et al., 2011). 
Moreover, the most successful innovators will have relatively less to learn from R&D 
collaboration partners. These considerations suggest that highly successful innovators may 
benefit relatively less from R&D collaboration (Khanna et al., 1998). 
 There are strong reasons to believe that the risk of knowledge dissipation is greatest in 
R&D collaborations with competitors (Blomqvist et al., 2005; Hurmelinna-Laukkanen and 
Olander, 2014; Belderbos et al., 2004). In general, the probability of opportunistic behavior 
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by partners in R&D collaboration is reduced through mutual dependence (Gulati & Sytch, 
2007), and the expectation of durability provides the confidence that investments in the R&D 
collaborative projects can indeed be recouped (Gilsing and Nooteboom, 2006). This mutual 
dependence is however likely to be relatively weak in the case of competitor R&D 
collaboration. Here competition policy often dictates pre-competitive R&D collaboration. 
Firms collaborate in the development of technology but subsequently compete in the product 
market in the commercialization phase. In addition, horizontal partners may be eager to 
collaborate with highly innovative firms because they see a potential to learn 
disproportionately from the R&D collaboration (Ahuja, 2000a). This increases the risk for 
innovation leaders that their partners engage in freeriding to benefit in the commercialization 
stage. 
 The above concerns are mitigated in R&D collaborations with vertical partners and with 
universities & research institutions. R&D collaboration with vertical partners is characterized 
by more durable, mutual dependence including commercialization and continuous 
improvements, while inputs of upstream and downstream partners may remain a necessity 
also for innovation leaders to sustain their lead (Tidd et al., 2015; Gulati & Sytch, 2007). 
Highly innovative firms may also have more opportunities and incentives to establish R&D 
collaborations with universities as their strong innovation capacity enables them to 
understand and apply state-of-the-art, academic expertise (e.g. Cassiman et al., 2009). Risks 
of spillovers and misappropriation are limited as university and public research institutions 
generally do not have commercialization objectives. 
 These arguments suggest that innovative performance may provide opportunities and 
inducements for vertical R&D collaboration and for R&D collaboration with universities & 
research institutes. However, for competitor R&D collaboration the situation differs. At a 
low(er) level of innovation performance, R&D collaboration with competitors may be 
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attractive as there is room to learn from others and relatively little to lose, suggesting a 
positive influence on new collaboration formation. At higher levels of innovation 
performance, however, knowledge dissipation risks become greater, while inducements are 
reduced as the potential to learn from others diminishes. For the most innovative firms a 
resulting negative ‘inducement’ to engage in R&D collaboration (Ahuja, 2000a) is likely to 
outweigh the greater opportunities to engage in R&D collaboration with competitors, 
suggesting a negative influence on collaboration formation.  
 Overall, these arguments apply a positive association between prior innovative 
performance and R&D collaboration with vertical and institutional partners, while a positive 
relationship with competitor R&D collaboration is likely to diminish and eventually become 
negative with higher levels of prior innovative performance. This leads to the following 
hypotheses: 
 
Hypothesis 5a: Past innovative performance is positively associated with a firm’s propensity 
to augment its portfolio of R&D collaboration types by newly establishing R&D 
collaboration with customers, suppliers, and universities & research institutes.  
 
Hypothesis 5b: Past innovative performance has an inverted U-shaped association with a 
firm’s propensity to augment its portfolio of R&D collaboration types by newly establishing 
R&D collaboration with competitors.  
 
DATA AND METHODS 
Data and sample 
The empirical analysis uses data from the Spanish Survey of Technological 
Innovation PITEC (Panel de Innovación Tecnológica). The survey is carried out by the 
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Spanish National Statistics Institute (INE), the Spanish Foundation for Science and 
Technology (FECYT) and the Foundation for Technological Innovation (COTEC). The 
PITEC dataset is well-suited for the investigation of our research questions and has several 
advantages that we exploit in our research. The first advantage is that the survey contains 
information on firms’ innovation activities, including questions on R&D collaboration, and is 
conducted annually starting from 2004 onwards. This feature is important for our analysis of 
specific patterns of inter-temporal interrelationships among R&D collaborative agreements. 
Second, the PITEC survey follows guidelines in the Oslo Manual (OECD, 2005) and is 
therefore comparable to the Community Innovation Survey (CIS) that is conducted every two 
years on behalf of Eurostat and constitutes a main survey instrument to garner harmonized 
data on firm innovation activities in the EU. The third advantage is that PITEC is designed as 
a panel data survey, with high compatibility in firm sampling across the different waves, 
which helps mitigate problems of attrition and selection, and allows the use of lagged 
explanatory variables in the analysis. Fourth, the survey covers firms operating in all sectors 
of the Spanish economy according to the CNAE-93 classification and is representative of the 
population of firms engaged in innovation activities.2 
The PITEC questionnaire has a multi-layer structure. Only those firms that report to 
be engaged in innovative activities are asked to complete the entire questionnaire and are the 
focus of our analysis. Apart from this selectivity – we explain how we deal with it in the 
methods section – most firms are observed for the entire period, and the panel is strongly 
balanced in nature. Our analysis focuses on firms active in manufacturing industries and 
requires that we observe a firm at least three consecutive years to establish inter-temporal 
patterns of past R&D collaboration and the relationship with newly established R&D 
                                                 
2 A more detailed description of the data and sampling can be found on the FECYT web site: 
http://icono.fecyt.es/pitec/Paginas/por que.aspx.  
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collaborations. The dependent variables are measured in year t and we use information from 
the previous survey(s) conducted in year t-1 and in year t-2 to construct the focal independent 
variables. This approach resulted in a sample covering 6055 firms, for which we jointly have 
26608 observations for the years 2006-2011.  
 
Measures 
Dependent variable: R&D collaboration with a new partner type. To construct the 
dependent variable(s), we use answers to the questions from the PITEC surveys pertaining to 
a firm’s R&D collaboration with customers, suppliers, competitors and universities & 
research institutes. Each of the four dependent variables is a binary (yes/no) indicator of 
whether a firm established new R&D collaboration in a year with respectively, suppliers, 
customers, competitors, and universities & research institutions. Since we focus on changes 
in portfolios or R&D collaborations with different partner types and examine newly formed 
R&D collaboration with these specific partner types, this implies that we restrict the analysis 
to those firms that had no existing R&D collaboration with the specific partner type in the 
year before. The dependent variable new customer R&D collaboration, for instance, takes the 
value 1 (else zero) if a firm reported engagement in R&D collaboration with a customer in 
the survey of year ݐ but not in the survey of year	ݐ െ 1. The indicators of new supplier, new 
competitor and new university R&D collaboration are constructed analogously. 
Prior R&D Collaboration. In our analysis we differentiate between each of the 
partner types among R&D collaborations that started in year	ݐ െ 1 (recently established or, 
recent), R&D collaboration agreements that started in year ݐ െ 2 and continued in year	ݐ െ 1 
(persistent) and R&D collaboration that started in year ݐ െ 2 but was discontinued in year	ݐ െ
1 (prior discontinued). These different types and patterns of prior R&D collaboration (in year 
ݐ െ 1 and in year	ݐ െ 2) are examined as antecedents of the establishment of R&D 
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collaborations with new partner types in year t. For instance, recent R&D collaboration with 
customers takes the value 1 (else zero) if a firm was cooperating with customers in year ݐ െ
1	but not in year	ݐ െ 2. Persistent involvement in R&D collaboration with customers takes 
the value 1 (else zero) if a firm reports R&D collaboration with customers in year ݐ െ
1	and	ݐ െ 2, i.e. in two consecutive prior surveys. Prior discontinued R&D collaboration 
with customers takes the value 1 if a firm was engaged in R&D collaboration with customers 
in the survey of t-2 but not in the survey in t-1. Recent, persistent, and prior discontinued 
R&D collaboration with suppliers, competitors and universities & research institutions are 
constructed analogously. Hypotheses 1 - 4 predict various relationships between these types 
of existing R&D collaborations with different partner types and firms’ propensity to augment 
their portfolio with other R&D partner types.3 
Past innovative performance is defined as the logarithm of sales from products that 
are new to the market divided by the total number of employees (cf. Belderbos et al., 2004b). 
We define this performance measure in deviation from the (2-digit) industry mean to account 
for the fact that the pace of product renewal and technological change varies across 
industries, and that macroeconomic shocks may affect industries differently.4 Sales of 
products new to the market is an often used indicator of (successful) innovations (e.g. Faems 
et al., 2005; Leiponen and Helfat, 2011). New to the market products can be seen as more 
                                                 
3 We also estimated models with 3 year lags for persistent prior R&D collaboration. This reduced the 
sample of observations by a large margin. Results were qualitatively similar but with higher estimated 
standard errors. There was no indication that the effects of persistence were stronger when measuring 
this over a longer prior period.  
4 Substituting the simple percentage of innovative sales in total sales as a performance measure leads 
to indiscriminate empirical results across collaboration types, with positive linear and negative square 
terms. We take this as indicating that this measure is less able to properly distinguish differences in 
relevant innovation performance across firms. Substituting an alternative measure that includes 
efficiency considerations - innovative sales over R&D - does produce qualitative similar results with 
an inverted-U shaped relationship only discernable for competitor collaboration.  
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‘radical’ in the sense that products are not just new to the firm, but also putting the firm ahead 
in its industry. The scaling by the number of employees to arrive at a productivity measure 
assures that the performance measure is not size-related or right censored and that the 
efficiency of the innovative process (where R&D collaboration will play a key role) is taken 
into account.5 We allow for non-linear relationships between past innovative performance 
and the propensity to establish R&D collaborations with new partner types by including the 
squared term of the past innovative performance in our model. 
Control variables 
We include R&D intensity as a key input into the innovation process and as a source 
of absorptive capacity benefitting R&D collaboration. We take the broadest definition of 
R&D available in the innovation survey that includes intramural R&D, expenditures on 
external R&D (acquisition of technologies, R&D contracting) and expenditures on marketing 
and design of innovations.  
Firm size is measured as the logarithm of the firm’s number of employees. Larger 
firms are more likely to be engaged in broader technology development activities and are 
more likely to require R&D collaboration with different partner types (Freel 2003; Bayona et 
al. 2001; Becker and Dietz 2004). 
We control for the export intensity of the firm because firms have been found to ‘learn 
by exporting’ by operating in international markets, gaining access to technical expertise and 
ideas from foreign customers and competitors. This process may involve establishing R&D 
collaborations with foreign firms to have broader access to locally embedded knowledge (e.g. 
Woerter and Roper, 2010; Salomon and Shaver, 2005).  
                                                 
5 Taking a productivity measure also aligns with extant literature relating innovation and best practice 
specifically to productivity (e.g. Bloom et al. 2012). 
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The variable resource constraints captures factors hampering the innovation process 
of a firm, potentially pushing the firm to engage in R&D collaboration. Extant literature 
suggests that existing constraints can be an important motive for technology partnering 
(Drechsler and Natter, 2012; Garriga et al., 2013). On the other hand, constraints on resources 
may also render the firm less attractive as R&D collaboration partner, and may reduce the 
general intensity of its innovative activities, including R&D collaborative endeavors. We 
create a resource constraints variable from survey items related to the following topics: 1) 
bottlenecks in the innovation process caused by high costs or lack of financial resources 2) 
uncertainty about market conditions 3) organizational bottlenecks 4) shortage of qualified 
(R&D) human resources 5) lack of information. Following Garriga et al. (2013) we coded 
these items as binary variables indicating the presence or absence of the constraint 
(Chronbach’s α=0.76) and then added them up.  
The analysis includes a patent dummy, which takes the value one (else zero) if a firm 
used patents as a means to protect its inventions. The possession of patents may provide firms 
with reputational value as effective innovators. Prior studies also have suggested that the 
capability of firms to protect and appropriate the fruits of technology development (through 
patents) generally has a positive effect on innovation and R&D collaboration (e.g. 
Hurmelinna-Laukkanen, 2011). In addition, the analysis controls for the patent productivity 
of the firm, defined as the ratio of the number of patent applications (during the past three 
years) to R&D expenditures. This variable controls for firms‘ broader propensity to enhance 
appropriation of their technological inventions through patents, as well as for differences in 
firms’ technological performance after controlling for R&D inputs.  
Our models also include the ratio of the firm’s expenditure on applied and basic 
research (i.e. the ‘R’ part of R&D) to the firm’s expenditures on development (the ‘D’ part of 
R&D). Prior research has emphasized different roles played by ‘R’ and ‘D’ in fostering 
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innovation (e.g. Barge-Gil and Lopez, 2015). While basic and applied research is geared 
towards acquiring complex and tacit knowledge, development is more focused on applied and 
codified knowledge. R&D collaboration with universities & research institutes may for 
instance be more strongly associated with a higher ratio of ‘R’ to ‘D’. 
Finally, the model includes a set of 18 industry dummies and a set of year dummies. 
All time-variant control variables are lagged by one year. 
 
Empirical Model 
We estimate a model in which we explain the propensity of a firm to start R&D 
collaboration with a new partner type depending on the patterns of prior R&D collaboration 
and past innovative performance. In order to analyze the propensity of firms to form new 
R&D collaborations with each type of partner, we estimate four binary choice equations for 
R&D collaboration with competitor, customer, supplier and universities & research institutes. 
Since these decisions are taken simultaneously we estimate the equations jointly, using a 
multivariate limited dependent variable model (Roodman, 2011) allowing for correlated error 
terms across equations. Such correlations are likely if there are benefits in joint new R&D 
collaboration engagement, or in case there are omitted variables in our empirical model of 
these choice processes. We estimate these models with robust standard errors clustered by 
firm. The general form of our model is as follows: 
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where y1, y2 , y3 and y4 are the four binary dependent variables, i.e. new customer, supplier, 
competitor and institutional R&D collaboration and (ω1 ω2 ω3 ω4) ~ N (0, Σ ) where  is the 
covariance matrix of the error terms. 
Although our focus is on specific patterns of inter-temporal interrelationships between 
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R&D collaborative R&D with different types of partners in order to test our hypotheses, our 
empirical model includes a full set of indicators of prior R&D collaboration. This is because 
we cannot rule out that different types of interrelationships exist beyond the hypothesized 
relationships, such that limiting the analysis to a specific set of prior R&D collaboration 
patterns may lead to omitted variable bias.  
To address potential sample selection concerns due to our focus on innovation-active 
firms from an initial larger selection of firms, we implemented a two-stage approach, 
correcting for selection effects. We estimated a first-stage probit model that explains firms’ 
propensity to be an innovator and subsequently include the Inverse Mill’s ratio of this 
equation as an additional covariate in the R&D collaboration models (e.g. Hass and Hansen, 
2005). In the first stage model we include firm size, export orientation (as the pressure to 
innovate and renew products is likely to be greater for firms competing in international 
markets), and a dummy that equals one (else zero) if a firm is newly established. Recent 
research has shown that young firms are often more innovative compared to their established 
counterparts (Schneider and Veugelers, 2010). In addition, we include a dummy variable for 
firms that are part of a business group, as being a part of a larger business group can provide 
input to innovation-orientated activities of the focal firm. Finally, we include industry and 
time dummies. The first stage model was highly significant with all covariates having a 
significantly positive coefficient.  
 
EMPIRICAL RESULTS 
Table 2 contains summary statistics and the bivariate correlations between the 
variables used in the estimation. Supplier and institutional R&D collaboration are most 
prominent, while R&D collaborations with competitors and customers are observed much 
less frequently. Persistent R&D collaboration in general is more frequently observed than 
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new or discontinued R&D collaboration. In addition we can report that for 3407 firm-year 
observations, at least one R&D collaboration agreement with customers, suppliers, 
competitors or research institutes and universities is reported. Firms on average have an R&D 
intensity of close to four percent, and about 80 percent of the sample firms are exporters. The 
variance inflation factor (VIF) values (with a mean of 2.6 across all variables) do not indicate 
multi-collinearity concerns.  
INSERT TABLE 2 
The empirical results of the multivariate limited dependent variables model explaining the 
formation of new R&D collaboration with suppliers, customers, competitors and universities 
& research institutions are displayed in Table 3, in columns 1 through 4. The bottom pane of 
the table reports the estimated correlations between the errors terms of the equations, which 
are all significant (p<0.01), confirming that a multivariate model taking these correlations 
into account is to be preferred. The Inverse Mills ratio is negative and significant in three of 
the four equations, suggesting that selection effects are present, and indicating, as expected, 
that the inverse of the probability that firms are innovators is negatively related to firms’ 
propensity to establish new R&D collaborations. The model has a proper fit, as indicated by 
the significant log-likelihood ratio test, and has satisfactory predictive power as indicated by 
the area under the ROC curve statistic (Hosmer and Lemeshow, 2000; StataCorp, 2015): a 
statistic of approximately 0.8 indicates acceptable levels of discrimination between the 
absence or presence of new R&D collaborations.6 Further analysis also showed that the 
                                                 
6 The ROC is an aggregate indicator of predictive power proposed by Hosmer and Lemeshow (2000) 
that measures the rate (0-1) of correct predictions of occurrence and non-occurrence of the focal 
phenomenon (new R&D collaboration in our case). We also confirmed a substantial and significant 
improvement in model fit compared to a model including only the control variables.  
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inclusion of the focal variables leads to a significant and substantial improvement in model fit 
for each dependent variable.7  
INSERT TABLE 3 
In support of hypothesis 1a, the empirical results show (column 1 of Table 3) that 
both recent (p<0.01) and persistent (p<0.1) customer R&D collaboration exert a positive 
influence on the probability that a firm starts R&D collaboration with suppliers. Similarly, in 
support of hypothesis 1b, results show (see column 2 of Table 3) that both recent (p<0.01) 
and persistent (p<0.01) supplier R&D collaboration exert a positive influence on the 
probability that a firm starts R&D collaboration with customers. Discontinued customer 
(supplier) R&D collaboration, in contrast, is not significant in the supplier (customer) 
equation – consistent with hypotheses 1a and 1b. 
Hypothesis 2 predicts that firms that discontinued R&D collaboration with 
competitors in t-1 have a higher propensity to start R&D collaboration with suppliers, 
customers and universities & research institutes. The coefficient on discontinued competitor 
R&D collaboration is positive and (weakly) significant in the supplier (p<0.1), customer 
(p<0.1) and universities & research institutes (p<0.1) equations. In contrast, the coefficients 
on recent and persistent competitor R&D collaboration are all insignificant. These results 
provide qualified support for hypothesis 2.  
In support of Hypothesis 3, the results suggest that prior persistent R&D collaboration 
with universities & research institutes is a significant antecedent of the start of R&D 
collaborations across all other partner types in line with hypothesis 3, with persistent 
institutional R&D collaboration significant at the 1 or 5 percent level in the supplier, 
customer and competitor equations. At the same time, recent R&D collaboration with 
                                                 
7 Estimating separate probit models, we confirmed that the fit of the individual models and the pseudo 
R2 improved considerably and significantly (LR tests).   
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universities & research institutes is positively associated with the start of supplier and 
competitor R&D collaboration, but not with customer R&D collaboration. 
Hypothesis 4 predicts that firms that discontinued their cooperative R&D 
relationships with a particular type of partner previously (in year t-1), have a higher 
probability of re-establishing R&D collaboration with that partner type in the future (year t). 
The results provide strong support for this hypothesis, as prior discontinued R&D 
collaboration has a positive and significant (p<0.01) influence on the (re)start of R&D 
collaboration for every type of partner (suppliers, customers, competitors and research 
institutions). This is a salient finding because such a positive influence of discontinued R&D 
collaboration is not observed across partner types, apart from the hypothesized effects of 
prior discontinued competitor R&D collaboration.  
Table 3 shows that past innovative performance has a positive association with the 
formation of R&D collaboration with suppliers and universities & research institutes. In these 
cases, the relationship is linear (the quadratic term is insignificant) as hypothesized. For 
customer R&D collaboration, innovative performance does not appear to be a significant 
factor in increasing the propensity for R&D collaboration. However, if in further tests (not 
shown due to space limitations) the quadratic term is omitted, the results reveal a strongly 
significant linear relationship. The only R&D collaboration type for which negative effects of 
innovative performance may occur is competitor R&D collaboration. With a significant 
positive linear term and a significant negative squared term, the estimates confirm an 
inverted-U shaped relationship. The estimated coefficients suggest that innovative 
performance has a positive marginal effect on propensity to establish competitor R&D 
collaborations up to roughly the top decile in the sample distribution, after which 
performance reduces the probability to start R&D collaboration with competitors. Overall, 
these findings provide broad support for Hypothesis 5.  
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The implied size of the effects of different patterns of prior R&D collaboration on the 
propensity to establish R&D collaborations with new partner types are substantial. The 
coefficients suggest that existing engagement in R&D collaboration, depending on the 
relationship between types, can easily double the probability that a firm establishes a new 
type of R&D collaboration. For instance, existing customer R&D collaboration more than 
doubles the probability that a firm starts R&D collaboration with suppliers (120 percent), and 
existing supplier R&D collaboration increases the probability of new engagement in 
customer R&D collaboration by 90 percent. The strongest effects are estimated for the re-
establishment of existing partner type R&D collaboration (the effect of prior discontinued 
R&D collaboration), with effect sizes between 115 and 175 percent (the latter for 
discontinued supplier R&D collaboration).  
The results reveal a number of additional relationships between prior R&D 
collaboration and the likelihood of establishing R&D collaborations with new partner types. 
While existing R&D collaboration with universities & research institutes is a precursor of 
R&D collaboration with other partner types, prior (recent or persistent) supplier and customer 
R&D collaboration in turn increases the probability that firms start institutional R&D 
collaboration. This suggests a broader complementarity between these collaborative ties in 
R&D. In general, supplier and customer R&D collaboration appear to have broader relevance 
as a precursor of the start of R&D collaboration with other partner types.  
The results for the control variables show that larger firms, more R&D intensive 
firms, exporting firms and firms applying for patents are more likely to establish R&D 
collaborations with new partner types. One exception is an insignificant coefficient on R&D 
intensity in the competitor R&D collaboration equation. A possible explanation is that firms 
with relatively abundant R&D resources and funds for the marketing and introduction of 
innovations have less need to forge new R&D collaborative ties, while such ties with 
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competitors in addition face the risk of dissipation of knowledge to direct rivals in the 
product market (e.g. Belderbos et al., 2004; Ritala et al., 2015). The same logic may apply to 
a negative coefficient on patent productivity: successful firms with proprietary knowledge to 
protect are relatively less likely to start R&D collaboration with competitors. Consistent with 
expectations, higher ratios of ‘R’ to ‘D’ expenditures are associated with the start of R&D 
collaboration with universities & research institutes. This also holds for supplier R&D 
collaboration but not for competitor and customer R&D collaboration.  Finally, firms 
experiencing constraints on resources are less likely to start R&D collaborations with 
suppliers or customers, perhaps because these constraints also hamper new commitments to 
R&D in collaborative projects.  
 
CONCLUSION AND DISCUSSION 
Key findings 
Whereas operating R&D collaboration portfolios is seen as carrying significant outcome 
effects for firms (e.g., Jiang, Tao, and Santoro, 2010; Hashai et al., 2015), prior studies have 
not paid due attention to the question how firms’ R&D collaboration portfolios are adapted 
and what the main drivers of such adaptations are. Our study addresses this issue and takes a 
dynamic and integrative approach to analyze the adaptation of firms’ R&D collaboration 
portfolios consisting of different partner types (customers, suppliers, competitors, and 
research institutes and universities).  
 We find support for a hypothesized strong interrelationship between new customer 
(supplier) R&D collaborative R&D ties and prior supplier (customer) R&D collaboration, 
which we attribute to the advantages of close intertemporal alignment of R&D collaboration 
with value chain partners.  Close alignment allows knowledge exchange and coordination to 
take place in ‘real time’, reduces the risks of inconsistencies across value chain steps, 
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improves efficiency by elimination of duplicative efforts, and decreases chances of 
misunderstanding. In contrast, prior horizontal R&D collaboration with competitors only has 
a positive effect on the formation of R&D collaboration with a new partner type if the R&D 
collaboration with competitors was first discontinued. This confirms our hypothesis that a 
sufficient lag between competitor R&D collaboration and R&D collaboration with other 
partner types mitigates governance risks related to undesirable knowledge spillovers and free-
ridership across collaborations with the different types if partners. Hence, in case of existing 
competitor R&D collaboration, there is a delayed rather than a close intertemporal alignment 
of R&D collaboration with other partner types.  
We also observe that prior R&D collaboration with public research institutions and 
universities is an important antecedent of the start of R&D collaboration with other partner 
types, in particular when such R&D collaboration with institutions is persistent – although 
(weaker) positive relationships are also found for more recently established institutional R&D 
collaboration.  Institutional R&D collaboration can give incentives and opportunities to 
augment the R&D collaboration portfolio with other partner types because the novel, generic 
knowledge and new technologies generated can be exploited in more applied R&D 
collaborative projects with other partner types. Institutional R&D collaboration offers firms 
opportunities to better assess which (R&D collaborative) trajectories in applied research will 
be most promising, and to benefit from positive reputational effects of involvement in 
collaborative university research.   
Empirical results confirmed a stylized pattern of a renewed R&D collaboration: 
discontinued R&D collaboration with a partner type increases the probability of a subsequent 
restarting of R&D collaboration with that type of partner. If a given R&D collaboration fails 
because the existing collaborating firm or institution is no longer the best match or willing to 
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continue, resource constraints and innovation needs will favor re-initiation of R&D 
collaboration with the same partner type addressing the same strategic need.  
Finally, we identify a key role of past innovative performance in adaptation of R&D 
collaboration portfolios by adding R&D collaboration with new partner types. Firms with 
better past innovative performance (in terms of their productivity in bringing new products to 
the market) are generally more likely to start R&D collaborations with new partner types 
subsequently, which will be due to the fact that they are more attractive as R&D collaboration 
partners. However, this is not the case for 'horizontal' R&D collaboration with competitors. 
Here the risk of dissipation of know-how to rivals - with potential detrimental effects on a 
firm's market position - discourages R&D collaboration by firms with the strongest 
innovative performance.  
 
Contributions and Implications for Theory 
A first insight that our study contributes to the literature on R&D and R&D 
collaboration (e.g. Rothaermel & Deeds, 2004; Gilsing et al., 2008; Gittelman & Kogut, 
2003; Srivastana and Gnyawali, 2011), is that  the adaptation of R&D collaboration portfolios 
follows distinctly different patterns depending on the type of partner. Here our study extends 
prior work considering adaptations of alliance portfolios with a focus on the distinction 
between exploration and exploitation alliances (Koza & Lewin, 1998, Rothaermel & Deeds, 
2004). Our results on the role of institutional (university) collaboration as driver of the 
subsequent formation of collaborations with other partner types is broadly in line with earlier 
findings that the more explorative alliances create a subsequent need for exploitation 
alliances (Rothaermel & Deeds, 2004) – although our study suggests that this pattern is 
strongest for persistent institutional collaboration. At the same time, whereas prior studies 
suggest a uniform relationship running from exploration to exploitation alliances, our study 
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contributes by showing that there also is considerable heterogeneity in alliance formation 
dynamics. Opening up the black box of different partner types reveals a dynamic pattern of 
start, dis-continuation and renewal of collaboration as well as considerable differences in 
these patterns across partner types. Whereas temporal alignment is critical for accomplishing 
complementarity across different partner types, how this is achieved differs profoundly 
between vertical and horizontal R&D collaboration, with attendant consequences for the 
adaptation of the R&D collaboration portfolio with new partner types. For vertical R&D 
collaboration temporal alignment needs to be (very) close in time in order to reap 
coordination advantages, but for horizontal R&D collaboration there is delayed alignment to 
reduce the risk of knowledge dissipation to rivals.  
A second new insight with relevance to the literature on R&D and R&D collaboration 
is that prior innovation performance also serves as an antecedent of the adaptation of the 
R&D collaboration portfolio with new partner types, yet that its influence also differs 
between partner types: horizontal R&D collaboration with competitors forms the exception. 
Our findings here shed more light on the ‘opportunities and inducement’ framework of Ahuja 
(2000a): while firms may have clear opportunities to initiate R&D collaborations with a new 
partner type and have sufficient absorptive capacity to potentially benefit from R&D 
collaboration (Spithoven et al., 2010), they may still have insufficient inducements for 
horizontal R&D collaboration with competitors if they fear that rival firms may benefit 
asymmetrically from the agreement. Hence, we highlight that there is a fundamental 
difference between horizontal R&D collaboration with competitors vis-à-vis vertical R&D 
collaboration with suppliers and customers and R&D collaboration with institutions - both in 
terms of temporal alignment and in the recursive effect of prior innovation performance. This 
insight contributes to a more in-depth understanding of the heterogeneous drivers of a firm’s 
R&D collaboration portfolio adaptations.   
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Third, whereas in previous work on alliance networks the role of relational, structural 
and positional embeddedness (Gulati and Garguilo, 1999; Stuart et al., 1999) has been 
emphasized in the formation of collaborative R&D ties, or the role of partners’ resources (e.g. 
Ahuja et al., 2009), our study suggests that it is critical to also consider heterogeneity across 
partner types. The majority of network embeddedness studies has abstracted from a partner’s 
role along the value chain, or has considered either horizontal (e.g. Ahuja, 2000b) or vertical 
types (e.g. Gulati & Sytch, 2007). Our study shows that there is strong heterogeneity in how 
different partner types influence the formation of R&D collaboration with new partner types. 
Apart from the role of embeddedness and partners’ resources (‘nodal attributes’ in network 
parlance) in explaining the formation of new R&D collaborations, a firm’s recently 
established, persistent and prior discontinued R&D collaborations with the same or different 
partner types are of significant influence. We suggest that future research takes into account 
the specific roles and functions of R&D collaborations with different partner types.   
Another implication of our study relates to the recursive process between the 
formation of R&D collaborations and performance outcomes. The dominant focus in 
different bodies of literature until now has been on either antecedents or performance 
consequences of R&D collaboration – but examined these in isolation. Moreover, these 
literatures have  investigated this in a rather compartmentalized manner, either from a 
resource dependency based perspective emphasizing the sharing of resources and strategic 
interdependence (e.g. Gulati and Gargiulo, 1999; Hagedoorn, 2002; Powell et al., 1996), from 
a network structural perspective emphasizing the network position of partners (e.g. Ahuja, 
2000b; Rowley et al., 2000), or from an industrial organization perspective emphasizing the 
internalization of knowledge spillovers (e.g. Belderbos et al., 2004a). These different lines of 
research share a common assumption of a linear process of antecedents leading to the 
formation of collaborative R&D ties, which subsequently leads to performance. This 
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approach is also often taken in prior studies analyzing the evolution of R&D collaboration 
portfolio emphasizing how exogenous changes in the environment affect portfolio change 
(e.g. Koza & Lewin, 1988, Koka et al., 2006; Lavie & Singh, 2012).  
Our study instead has adopted a strategy perspective to show how the decision to start 
R&D collaboration with a new partner type and adapt the R&D collaboration portfolio is a 
dynamic function of a firm’s recently established, persistent or prior discontinued R&D 
collaborations. This is reflective of a more agency-oriented understanding that demonstrates 
how, once R&D collaborations with a partner type are formed, continued, or discontinued, a 
sequence of further decisions unrolls on the formation of new R&D collaboration with 
different partner types. The pervasive role of these inter-temporal dynamics, in which R&D 
collaborations with other partner types are added to firms’ R&D collaboration portfolios, is 
indicative of several key processes in inter-firm R&D collaboration that have not been 
captured by the common, linear approach to the analysis of antecedents and performance 
consequences of R&D collaboration dominating the literature thus far. Our study in this 
regard ties into an emergent stream in the literature that is concerned with opening the ‘black 
box’ of the R&D collaboration process, studying the intricacies and micro-mechanisms of 
how firms can realize the potential value of R&D collaboration (see e.g. Kauppila, 2015; 
Hipkin and Naudé, 2006; Newell et al., 2008; Cassiman et al., 2009). We suggest that future 
research on R&D and R&D collaboration should pay close attention to the dynamics of the 
growth in firms’ heterogeneous R&D collaboration portfolios, with the performance 
consequences of alignment and temporal patterns of R&D collaboration forming a promising 
avenue for further inquiry.  
Managerial implications 
 An important implication following from our study is that collaboration for 
innovation cannot be captured by a universal ‘best practice’, as is (implicitly) assumed or 
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sometimes even explicitly argued in the literature on e.g. open innovation (e.g. Chesbrough et 
al., 2014) or the more popular business press (e.g. Skarzynski and Gibson, 2008; 
Govindarajan, 2016). As several success stories on R&D collaboration for innovation have 
demonstrated (e.g. Procter and Gamble’s connect and develop program, IBM’s emerging 
business areas, or Lego’s radical innovation’s strategy, to name a few), and as demonstrated 
by different studies (Ahuja, 2000b; Rothaermel and Deeds, 2004; Gilsing et al., 2008), R&D 
collaboration for innovation holds the promise of delivering value and enhancing 
performance. Our study does not criticize these claims, but suggests that in order to maintain 
the ability of capturing value from R&D collaboration, firms may have to adapt the R&D 
collaboration portfolio on an ongoing basis (e.g. Koka et al., 2006; Ahuja et al., 2012). To 
accomplish this, and in order to benefit from its performance enhancing effects, it is 
important to be aware that a fundamental difference exists in the dynamics between R&D 
collaboration with competitors (horizontal) on the one hand, and R&D collaboration with 
suppliers and customers (vertical) and universities & research institutes (institutional) on the 
other hand. Hence, building up (R&D) alliance capabilities (Heimeriks et al. 2009) requires 
recognition of the distinct differences in collaboration processes depending on the partner 
type.  
A recently emerging phenomenon in business practice is an increasingly important 
role of (alliance) network managers, entrusted with steering and coordinating network 
activities, in particular  complex innovation networks such as, among others, R&D 
collaboration portfolios involving different partner types  (Landsperger et al., 2012; 
Heidenreich et al., 2016). The implication for firms and their network managers is that when 
setting up R&D collaborations with a new partner type, taking into account the nature of 
existing R&D collaborations is critically important. When collaborating with suppliers, 
customers and/or research institutions, temporal alignment is relatively easy and safe to 
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accomplish, enhancing a firm’s ability to adapt rapidly its portfolio of R&D collaborations if 
needed. This differs for R&D collaboration with competitors where the need for delayed 
alignment will reduce the speed of adaptability of a firm R&D collaboration portfolio. Hence, 
before setting up R&D collaboration with competitors, it is important to be aware that this 
comes not only at a price of elevated risks of spillovers and opportunism, but will also lower 
the speed of adaptation of the R&D collaboration portfolio if one wants to address these risks. 
Given the ever-increasing velocity in today’s dynamic business environments, which puts a 
premium on adaptability (Stieglietz et al., 2016), adaptation of R&D collaboration portfolios 
will form an increasingly critical issue to consider.   
 
Limitations 
We note a number of limitations of our research. First, our analysis relied on 
information concerning engagement in R&D collaboration with different partner types, but 
could not identify individual partners of the focal firms. Our theory and analysis therefore 
took a strategic perspective on the rationale for engagement in R&D collaboration with 
different partner types, rather than focusing on the start, longevity, and termination of 
individual R&D collaborations.  
Second, a number of aspects of the R&D collaboration patterns may be specific to the 
data on Spanish firms that we analyzed. In Spain, the majority of the national R&D effort is 
carried out by the public sector. Firms are therefore likely to have relatively strong incentives 
to cooperate with research institutions, and such R&D collaboration is often supported by 
public policies. This may explain why institutional R&D collaboration is rather well 
represented in our sample. We suggest that future work examines the patterns of dynamic 
interrelation and performance drawing on innovation surveys in other countries to investigate 
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the generalizability of our findings. Our analysis suggests that it will be important to access 
yearly data on R&D collaboration in order to unveil dynamic patterns of interrelation.  
Third, we examined new R&D collaboration as a function of past innovative 
performance - in an implicit recursive model. While this brought out salient and dynamic 
heterogeneity in collaborative R&D activities with different partners, we cannot infer 
causality. In general, while the lag structure helps to alleviate concerns about reverse 
causality, our analysis cannot rule out endogeneity stemming from unobserved heterogeneity 
and potential influences of long-term R&D collaborative ties on past performance. We 
therefore interpret our results as partial correlations (associations) rather than causal 
relationships. A challenge for future work is to integrate performance analysis and the 
analysis of the drivers of R&D collaboration within a single framework and system of 
equations.  
We hope that future research on R&D and R&D collaboration can pay close attention 
to the dynamics of the growth in firms’ heterogeneous R&D collaboration portfolios, with the 
performance consequences of alignment and temporal patterns forming a promising avenue 
for further inquiry. 
 
REFERENCES 
Ahuja, G., 2000a. The duality of R&D collaboration: inducements and opportunities in the 
formation of interfirm linkages. Strategic Management Journal 21(3), 317-43. 
Ahuja, G., 2000b. R&D collaboration Networks, Structural Holes, and Innovation: A 
Longitudinal Study. Administrative Science Quarterly 45, 425 – 455.  
Ahuja, G., Soda G., Zeheer A., 2012. The Genesis and Dynamics of Organizational Network. 
Organization Science, 23 (2), 434 – 448. 
Arranz, N., Arroyabe, J., 2008. The choice of partners in R&D collaboration: an empirical 
analysis of Spanish firms. Technovation 28, 88-100. 
41 
 
Baba, Y., Shichijo, N., Sedita, S., 2009. How do R&D collaborations with universities affect 
firms’ innovative performance? The role of “Pasteur scientists” in the advanced 
materials field. Research Policy 38(5), 756-64.  
Barge-Gil, A., Lopez, A. 2015. R versus D: estimating the differentiated effect of research 
and development on innovation results. Industrial and Corporate Change, 24(1), 93–129 
Barney, J., 1991. Firm Resources and Sustained Competitive Advantage. Journal of 
Management 17(1), 99-120.  
Bayona, C., Garcı́a-Marco, T., Huerta, E., 2001. Firms’ motivations for cooperative R&D: an 
empirical analysis of Spanish firms. Research Policy 30(8), 1289-1307. 
Becker, W., Dietz, J., 2004. R&D cooperation and innovation activities of firms—evidence 
for the German manufacturing industry. Research Policy 33(2), 209-23. 
Belderbos, R., Gilsing, V., Lokshin, B. 2012, Persistence of, and interrelation between 
horizontal and vertical technology alliances, Journal of Management, 38(6), 1788-1811. 
Belderbos, R., Carree, M., Lokshin, B., 2004. Cooperative R&D and firm performance. 
Research Policy 33(10), 1477-1492. 
Bercowitz, J.E.L. and M. P. Feldman, 2007. Fishing upstream: firm innovation strategy and 
university research alliances. Research Policy 36, 930 - 948. 
Birkinshaw, J., Fey, C., 2005. External sources of knowledge, governance mode, and R&D 
performance. Journal of Management 34(4), 597-621.  
Bleeke, J., Ernst, D., 1991. The way to win in cross-border alliances. Harvard Business 
Review 69(6), 127-35. 
Blomqvist, K., P. Hurmelinna and R. Seppanen, 2005. Playing the R&D collaboration game 
right – balancing trust and contracting. Technovation, 25, 497 – 504. 
Bloom, N., Genakos, C., Sadun, R., Van Reenen, J. (2012). Management Practices Across 
Firms and Countries, Academy of Mangement Perspectives, 26 (1), 12-33.  
Brown, S. Eisenhardt, K., 1995. Product Development: Past Research, Present Findings, and 
Future Directions. Academy of Management Review, 20 (2), 343 – 378.  
Burt, R.S., 2004. Structural holes and good ideas. American Journal of Sociology 110(2), 
 349-99. 
Cassiman, B., Chiara Di Guardo, M. and Valentini, G. 2009. Organizing R&D projects to  
  profit from innovation: insights from co-opetition. Long Range Planning 42, 216 -  
  233.  
42 
 
Chesbrough, H., Vanhaverbeke W., West, J., 2014. New frontiers in open innovation. Oxford 
University Press, Oxford (UK). 
Childerhouse, P., Aitken, J., Towill, D., 2002. Analysis and design of focused demand chains. 
Journal of Operations Management 20(6), 675-89. 
Choi, T., and Hartley, J., 1996. An exploration of supplier selection practices across the 
supply chain. Journal of Operations Management 14(4), 333-43. 
Cockburn, I., Henderson, R., 1998. Absorptive Capacity, Coauthoring Behavior, and the 
Organization of Research in Drug Discovery. The Journal of Industrial Economics 
46(2), 157-82. 
Cohen, W.M., Nelson, R., Walsh, J., 2002. Links and Impacts: The Influence of Public 
Research on Industrial R&D. Management Science 48(1), 1-23. 
Colombo, M.G., Grilli, L., Piva, E. 2006. In search of complementary assets: The  
  determinants of alliance formation of high-tech start-ups. Research Policy 35, 1166- 
  1199. 
Christensen, C.M. and J.L. Bower (1996), Customer power, strategic investment and the 
failure of leading firms, Strategic Management Journal, 17, 197 – 218.  
Díez-Vial, I., 2007. Explaining vertical integration strategies: market power, transactional 
attributes and capabilities. Journal of Management Studies 44 (6), 1017-40. 
Drechsler, W., Natter, M., 2012. Understanding a firm’s openness decisions in innovation. 
Journal of Business Research 65, 438-45. 
Duysters, G., Lokshin, B., 2011. Determinants of alliance portfolio complexity and its effect 
on innovative performance of companies. Journal of Product Innovation Management 
28(4), 570-85. 
Faems, D., van Looy, B., Debackere, K., 2005. Interorganizational R&D collaboration and 
Innovation: Toward a Portfolio Approach. The Journal of Product Innovation 
Management 22(3), 238-50.  
Fey. C., Birkinshaw, J, 2005. External Sources of Knowledge, Governance Mode, and R&D 
Performance. Journal of Management, 31 (4), 597 - 621. 
Fisher, M., 1997. What is the right supply chain for your product? Harvard Business Review 
75, 105-16. 
Fleming, L., Sorenson, O., 2004. Science as a map in technological search. Strategic 
Management Journal 25(8-9), 909–28. 
Freel, M.S., 2003. Sectoral patterns of small firm innovation, networking and proximity. 
Research Policy 32(5), 751–70. 
43 
 
Frohlich, M., Westbrook, R., 2001. Arcs of integration: an international study of supply chain 
strategies. Journal of Operations Management 19(2), 185-200.  
Garriga, H., von Krogh, G., Spaeth, S., 2013. How constraints and knowledge impact open 
innovation. Strategic Management Journal 34(9), 1134-44. 
Gilsing, V.A., Nooteboom, B., 2006. Exploration and exploitation in biotechnology. 
Research Policy 35(1), 1-23. 
Gilsing, V., Nooteboom, B., Vanhaverbeke, Duysters, G., Oord van den A., 2008. Network 
embeddedness and the exploration of novel technologies: Technological distance, 
betweenness centrality and density. Research Policy, 37 (12), 1717 – 1731. 
Gittelman, M., Kogut, B, 2003. Does Good Science Lead to Valuable Knowledge? 
Biotechnology Firms and the Evolutionary Logic of Citation Patterns. Management 
Science, 49 (4), 366 – 382. 
Govindajaran, V., 2016. The three box solution, a strategy for leading innovation. Harvard 
Business Review Press, Cambridge (Ma.) 
Gregorio, D., Shane, S., 2003. Why do some universities generate more start-ups than others? 
Research Policy 32(2), 209–27. 
Gudergan, S., Devinney T., Franciscka Richter, N., R. Susan Ellis, 2012. Strategic 
implications for (non-equity) alliance performance. Long Range Planning, 45, 451 – 
476. 
Gulati, R., 1995. Does Familiarity Breed Trust? The Implications of Repeated Ties for 
Contractual Choice in Alliances. Academy of Management Journal 38(1), 85-112. 
Gulati, R., Garguilo, M., 1999. Where do interorganizational networks come from? American 
Journal of Sociology 104(5), 1439-93. 
Gulati, R., and Srivastava, S. B. (2014). Bringing Agency Back into Network Research: 
Constrained Agency and Network Action. BRASS, D, 73-93. 
Gulati, R., Sytch, M., 2007. Dependence asymmetry and joint dependence in 
interorganizational relationships: effects of embeddedness on a manufacturer’s 
performance in procurement relationships. Administrative Science Quarterly 52(1), 32 
– 69. 
Hagedoorn, J., 1993. Understanding the rationale of strategic technology partnering: 
interorganizational modes of cooperation and sectoral differences. Strategic 
Management Journal 14, 371-85. 
Hagedoorn, J., 2002. Inter-firm R&D partnerships: an overview of major trends and patterns 
since 1960. Research Policy 31, 477-92. 
44 
 
Harrigan, K.R., 1988. Strategic alliances and partner asymmetries. In F. Contractor, P. 
Lorange, eds. Cooperative Strategies in International Business. Lexington Books, 205-
26. 
Hashai, N., M. Kafouros and P. Buckley, 2015. The Performance Implications of Speed,  
  Regularity, and Duration in Alliance Portfolio Expansion. Journal of Management. 
Haas, M and M. Hansen 2005. When using knowledge can hurt performance: The value of 
organizational capabilities in a management consulting company, Strategic 
Management Journal 26: 1-24. 
Heidenreich, S., Landsperger, J. and Spieth, P. (2016): Are Innovation Networks in Need  
  of a Conductor? Examining the Contribution of Network Managers in Low and High  
  Complexity Settings, Long Range Planning, 49 (1), 55-71. 
Heimeriks, K. E. Klijn and E. Reuer, 2009. Building capabilities for alliance portfolios.  Long 
Range Planning, 42 (1), 96 – 114.  
Hipkin, I., Naudé, P., 2006. Developing effective alliance partnerships, lessons from a case 
study. Long Range Planning, 39, 39, 51 – 69.  
Hoffman, W., 2007. Strategies for managing a portfolio of alliances. Strategic Management 
Journal, 28 (8), 827 – 856. 
Hosmer D. and Lemeshow S. (2000). Applied Logistic Regression. Wiley, New York, second 
edition. 
Hurmelinna-Laukkanen, P. and H. Olander, 2014. Coping with rivals’ absorptive capacity in 
innovation activities. Technovation, 34, 3-11.  
Jiang, R. Q. Tao and M. Santoro, 2010. Alliance portfolio diversity and firm performance. 
Strategic Management Journal, 31 (10), 1136 – 1144. 
Kauppila, O., 2015. Alliance management capability and firm performance: using resource-
based theory to look inside the process black box. Long Range Planning, 48, 151 - 167. 
Khanna, T., Gulati, R., Nohria, N., 1998. The dynamics of learning alliances: competition, 
cooperation, and relative scope. Strategic Management Journal 19(3), 193-210. 
Killing, J., 1988. Understanding alliances: the role of tasks and organizational complexity. In 
F. Contractor, P. Lorange, eds. Cooperative Strategies in International Business. 
Lexington Books, 55-68. 
Kogut, B., 1989. The stability of joint ventures: Reciprocity and competitive rivalry. The 
Journal of Industrial Economics 38 (2), 183-198. 
45 
 
Koka, B., Madhavan R., Prescott, J. 2006. The evolution of interfirm networks: 
environmental effects on patterns of network change. Academy of Management 
Review, 31 (3), 712 - 731. 
Koza, M.P, Lewin, A.Y. 1998. The co-evolution of strategic alliances. Organization Science  
 9, 255-264.  
Lahiri, N. and S. Narayanan, 2013. Vertical integration, innovation, and alliance portfolio 
size: implications for firm performance. Strategic Management Journal 34 (9), 1042–
1064. 
Landsperger, J., Spieth, P. and Heidenreich, S. (2012): How Network Managers contribute to  
  Innovation Network Performance, International Journal of Innovation Management,  
  16 (6), 1240009. 
Lavie, D.; Kang, J., Rosenkopf, L., 2011. Balance within and across Domains: The 
Performance Implications of Exploration and Exploitation in Alliances. Organization 
Science 22(6), 1517-38. 
Lavie, D and Singh, H. 2011. The evolution of alliance portfolios: The case of Unisys. 
Industrial and Corporate Change, 21 (3), 763-809 
Lee, H., Padmanabhan, V., Whang, S., 1997. Information distortion in a supply chain: the 
bullwhip effect. Management Science 43(4), 546-58. 
Leiponen, A., and Helfat, E. 2011. Location, Decentralization and Knowledge Sources for 
Innovation, Organization Science, 22(3): 641-658. 
Leiponen, A. 2001. Why do firms not collaborate? The role of competencies and 
technological regimes, in: A. Kleinknecht and P. Mohnen (eds.), Innovation and Firm 
Performance, Palgrave, 253-277. 
Lhuillery, S., Pfister, E., 2009. R&D cooperation and failures in innovation projects: 
Empirical evidence from French CIS data. Research Policy 38(1), 45-57. 
Littler D., Leverick, F., 1995. Joint ventures for product development: learning from 
experience. Long Range Planning, 28, 58 - 67. 
Lokshin, B., Hagedoorn, J., Letterie, W., 2011. The Bumpy Road of Technology 
Partnerships: Understanding causes and consequences of partnership mal-functioning. 
Research Policy 40(2), 297-308. 
Mahoney, J.T., Pandian, J.R., 1992. The Resource-Based View Within the Conversation of 
Strategic Management. Strategic Management Journal 15(5), 363–80. 
Metters, R., 1997. Quantifying the bullwhip effect in supply chains. Journal of Operations 
Management 15(2), 89-100. 
46 
 
Mitchell, W., Singh, K., 1992. Incumbents’ use of pre-entry alliances before expansion into 
new technical subfields of an industry. Journal of Economic Behavior and Organization 
18(3), 347-72. 
Mitsuhashi, H., Greve, H., 2009. A matching theory of alliance formation and organizational 
success: complementarity and compatibility. Academy of Management Journal, 52 (5), 
975 – 995.  
Molina-Morales, X., Martinez-Fernandez, T., Torlo, V., 2011. The dark side of trust: the 
benefits, costs and optimal levels of trust for innovation performance. Long Range 
Planning, 44, 118 - 33. 
Monjon, S., Waelbroeck, P., 2003. Assessing spillovers from universities to firms: evidence 
from French firm-level data. International 21(9), 1255–70. 
Narasimhan, R., Jayaram, J., 1998. Causal Linkages in supply chain management: an 
exploratory study of North American manufacturing firms. Decision Sciences 29(3), 
579-605. 
Newell, S., Goussevskaia, A., Swan, J., Bresnen, M., Obembe, A., 2008. Interdependencies in 
complex project ecologies: the case of biomedical innovation. Long Range Planning, 
41, 33 – 54.  
Nieto, M.J., Santamaría, L., 2007. The importance of diverse R&D collaborative networks for 
the novelty of product innovation. Technovation 27(6), 367-77. 
OECD 2005. Oslo manual: Guidelines for collecting and interpreting innovation data, 3rd  
 Edition, Paris. 
Parkhe, A., 1993. Strategic alliance structuring, a game theoretic and transaction cost 
examination of interfirm cooperation. Academy of Management Journal 36, 794-829.  
Park, S. Russo, M. 1996. When competition eclipses cooperation: an event history analysis of 
joint-venture failure. Management Science, 42 (6), 875 – 890. 
Parmigiani, A., Rivera-Santos, M. 2011. Clearing a path through the forest: A meta-review of  
  interorganizational relationships. Journal of Management 37, 1108-1136. 
Peteraf, M., 1993. The Cornerstones of Competitive Advantage: A Resource-Based View. 
Strategic Management Journal 14(3), 179-91. 
Phelps, C., Heidl, R., Wadhwa, A., 2012. Knowledge, networks, and knowledge networks: a 
review and research agenda. Journal of Management 38(4), 1115-66. 
Powell, W.W., Koput, K.W. and Smith–Doerr, L., 1996. Interorganizational R&D 
collaboration and the locus of innovation: networks of learning in biotechnology. 
Administrative Science Quarterly, 41, 116 - 145.  
47 
 
Ritala, P., H. Olander, S. Michailova and K. Husted, 2015. Knowledge sharing, knowledge 
leakage and relative innovation performance: an empirical study. Technovation, 35, 22- 
31.  
Roodman, D., 2011. Estimating fully observed recursive mixed-process models with cmp. 
Stata Journal 11(2), 159-206. 
Rosenzweig, E.D., Roth, A.V., Dean, J.W., 2003. The influence of an integration strategy on 
competitive capabilities and business performance: an exploratory study of consumer 
products manufacturers. Journal of Operations Management 21(4), 437-56. 
Rothaermel, F.T., Deeds, D.L. 2004. Exploration and Exploitation Alliances in    
  Biotechnology: A System of New Product Development. Strategic Management  
  Journal 25(3), 201 – 221.  
Rothaermel, F.T., Deeds, D.L. 2006. Alliance type, alliance experience and alliance  
  management capability in high-technology ventures. Journal of Business Venturing  
 21, 429-460. 
Rowley, T., Behrens, D., Krackhardt, D., 2000. Redundant governance structures: An  
  analysis of structural and relational embeddedness in the steel and semiconductor  
  industries. Strategic Management Journal 21(3), 369-86.  
Roy, R., Whelan, R., 1992. Successful recycling through value-chain R&D collaboration.  
  Long Range Planning, 25, 62 – 71. 
Salomon, R. and Shaver, J. M. 2005. Learning by Exporting: New Insights from Examining  
  Firm Innovation. Journal of Economics and Management Strategy, 14: 431-460.	
Schneider, C., Veugelers, R. 2010. On young highly innovative companies: why they matter 
and how (not) to policy support them, Industrial and Corporate Change, 19(4), pp. 969–
1007 
Segarra-Blasco, A., Arauzo-Carod, J.M., 2008. Sources of innovation and industry–university 
interaction: Evidence from Spanish firms. Research Policy 37(8), 1283-95 
Skarzynski, P., R. Gibson, 2008. Innovation to the core, a blueprint for transforming the way 
your company innovates. Harvard University Press, Cambridge (Ma.).  
Spithoven, A., B. Clarysse and M. Knockaert, 2010. Building absorptive capacity to organize 
inbound open innovation in traditional industries. Technovation, 30, 130 -141.  
Srivastava, M.K., Gnyawali, D.R., 2011. When do relational resources matter? Leveraging 
portfolio technological resources for breakthrough innovation. Academy of 
Management Journal, 54 (4), 797 – 810. 
StataCorp. 2015. Stata 14 Base Reference Manual. College Station, TX: Stata Press, p. 1330. 
48 
 
Stieglietz, N., Knudsen Th., Becker M., 2016. Adaptation and inertia in dynamic 
environments. Strategic Management Journal 37 (1854 – 1864.  
Stuart, T.E., Hoang, H., Hybels, R.C., 1999. Interorganizational endorsements and the 
performance of entrepreneurial ventures. Administrative Science Quarterly 44 (2), 315-
349. 
Tasselli, S., Kilduff, M, Menges, J. 2015. The microfoundations of organizational social 
networks: a review and an agenda for future research. Journal of Management, 41 (5), 
1361 - 1387 
Tatarynowicz, A. Sytch, M., Gulati, R., 2016. Environmental demands and the emergence of 
social structure, technological dynamism and interorganizational network forms. 
Administrative Science Quarterly, 61 (1), 52 - 86 
Teece, D.J., 1980. Economics of scope and the scope of the enterprise. Journal of Economic 
Behavior and Organization 1, 223-47. 
Tether, B.S., 2002. Who co-operates for innovation, and why: an empirical analysis. 
Research Policy 31(6), 947-67. 
Tidd, J., Bessant, J., Pavitt, K., 2015. Managing innovation: Integrating technological, market 
and organizational change. John Wiley & Sons, Chichester. 
Un, C.A., Cuervo-Cazurra, A., Asakawa, K., 2010. R&D collaborations and product 
innovation. Journal of Product Innovation Management 27(5), 673-89. 
Veugelers, R., Cassiman, B., 2005. R&D cooperation between firms and universities. Some 
empirical evidence from Belgian manufacturing. International Journal of Industrial 
Organization 23 (5-6), 355-79. 
Vickery, S.K., Jayaram, J., Droge, C., Calantone, R., 2003. The effects of an integrative 
supply chain strategy on customer service and financial performance: an analysis of 
direct versus indirect relationships. Journal of Operations Management 21(5), 523-39. 
Von Hippel, E. (1988), The sources of innovation, Oxford University Press: Oxford.  
Wassmer, U., 2010. Alliance Portfolios: A Review and Research Agenda. Journal of 
Management, 36 (1), 141 - 171. 
Woerter, M., and S. Roper, 2010, Openness and innovation—Home and export demand 
effects on manufacturing innovation: Panel data evidence for Ireland and Switzerland, 
Research Policy, 39(1), pp. 155-164. 
49 
 
Wuyts, S. and S. Dutta and S. Stremersch, 2012. Portfolios of Interfirm Agreements in 
Technology-Intensive Markets: Consequences for Innovation and Profitability 
 Journal of Marketing 68 (2), 88 – 100.  
Zucker, L.G., Darby, M.R., Torero, M., 2002. Labor mobility from academe to commerce. 
Journal of Labor Economics 20(3), 629-60. 
  
50 
 
Table 1. Framework and Hypotheses 
 
Notes: hypothesized relationship in parentheses; n= negligible; ----- = not applicable 
 
 
 
 
            
Starting R&D collaboration with a new partner type: 
prior collaboration with suppliers customers competitors institutes
Suppliers
Recent ------ H1b (+)
Persistent ------ H1b (+)
Recently discontinued H4 (+) H1b (n)
Customers
Recent H1a (+) ------
Persistent H1a (+) ------
Recently discontinued H1a (n) H4 (+)
Competitors
Recent H2 (n) H2 (n) ------ H2 (n)
Persistent H2 (n) H2 (n) ------ H2 (n)
Recently discontinued H2 (+) H2 (+) H4 (+) H2 (+)
Institutes
Recent ------
Persistent H3 (+) H3 (+) H3 (+) ------
Recently discontinued H4 (+)
            
Prior innovation performance H5a (+) H5b (inverted-U) H5a (+) H5a (+)
            
Table 2. Descriptive statistics and pairwise correlations  
 
Variables Mean SD 1 2 3 4 5 6 7 8 9 10 11
1 New supplier collab (dv) 0.02 0.15
2 New customer collab (dv) 0.01 0.08 0.27
3 New competitor collab (dv) 0.01 0.08 0.17 0.25
4 New university & res. inst. (dv) 0.03 0.16 0.40 0.19 0.22
5 Innovation performance 0.27 1.82 0.04 0.04 0.03 0.03 
6 Innovation performance squared 3.38 5.01 0.04 0.04 0.02 0.02 0.81
7 Recent supplier collab 0.03 0.16 . 0.05 0.05 0.08 0.05 0.03
8 Recent customer collab 0.01 0.08 0.05 . 0.06 0.06 0.04 0.03 0.17
9 Recent competitor collab 0.01 0.08 0.03 0.01 . 0.05 0.03 0.02 0.10 0.12
10 Recent institutional collab 0.03 0.17 0.07 0.03 0.04 . 0.04 0.02 0.30 0.12 0.16
11 Persistent supplier collab 0.06 0.23 . 0.10 0.06 0.06 0.08 0.06 -0.04 0.10 0.05 0.06
12 Persistent customer collab 0.01 0.10 0.04 . 0.07 0.05 0.05 0.03 0.01 -0.01 0.03 0.04 0.30
13 Persistent competitor collab 0.01 0.09 0.02 0.03 . 0.02 0.05 0.03 0.01 0.01 -0.01 0.01 0.21
14 Persistent institutional collab 0.05 0.23 0.08 0.07 0.06 . 0.09 0.07 0.05 0.06 0.05 -0.04 0.46
15 Discontinued supplier collab 0.03 0.16 0.14 0.03 0.03 0.06 0.02 0.02 -0.03 0.01 0.02 0.01 -0.04
16 Discontinued customer collab 0.01 0.08 0.05 0.13 0.05 0.03 0.02 0.02 0.01 -0.01 0.01 0.01 0.08
17 Discontinued competitor collab 0.01 0.09 0.05 0.07 0.08 0.05 0.02 0.02 0.01 0.01 -0.01 0.01 0.06
18 Discontinued institutional collab 0.03 0.17 0.05 0.02 0.01 0.12 0.02 0.02 0.02 0.03 0.02 -0.03 0.05
19 Firm size 4.21 1.36 0.11 0.07 0.06 0.08 0.06 0.04 0.10 0.06 0.04 0.08 0.22
20 R&D intensity, % 3.71 6.16 0.02 0.02 0.01 0.02 0.08 0.02 0.02 0.02 0.01 0.03 0.02
21 Export intensity, % 10.56 18.31 0.04 0.05 0.05 0.04 0.05 0.05 0.05 0.05 0.05 0.03 0.07
22 Constraints on resources 1.77 1.86 -0.03 -0.02 -0.01 -0.02 -0.03 -0.03 -0.01 -0.01 0.00 0.00 -0.05
23 Patents/R&D 0.04 0.46 0.00 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.00 -0.01 -0.01
24 Patent dummy 0.16 0.37 0.05 0.07 0.04 0.05 0.17 0.10 0.07 0.06 0.01 0.06 0.11
25 ‘R’ to ‘D’ expenditures ratio 0.33 0.40 0.03 0.02 0.02 0.03 0.07 0.05 0.03 0.02 0.02 0.03 0.06
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 Table 2  Descriptive statistics and pairwise correlations (continued) 
 
Variables 12 13 14 15 16 17 18 19 20 21 22 23 24
13 Persistent competitor collab 0.13   
14 Persistent institutional collab 0.19 0.16  
15 Discontinued supplier collab 0.00 0.00 0.04  
16 Discontinued customer collab -0.01 0.03 0.06 0.24  
17 Discontinued competitor collab 0.06 -0.01 0.07 0.17 0.25  
18 Discontinued institutional collab 0.03 0.01 -0.04 0.32 0.16 0.18 
19 Firm size 0.10 0.06 0.19 0.09 0.07 0.05 0.06
20 R&D intensity, % 0.03 0.01 0.05 0.01 0.01 0.02 0.01 -0.25
21 Export intensity, % 0.06 0.06 0.05 0.04 0.05 0.05 0.03 0.09 0.04
22 Constraints on resources -0.03 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.22 0.10 -0.03
23 Patents/R&D -0.01 0.00 -0.01 -0.01 0.00 0.00 0.00 -0.03 -0.02 0.00 0.00
24 Patent dummy 0.04 0.04 0.10 0.03 0.05 0.03 0.04 0.11 0.11 0.09 0.00 0.18
25 ‘R’ to ‘D’ expenditures ratio 0.05 0.03 0.04 0.02 0.01 0.02 0.02 0.05 0.10 0.08 0.00 -0.01 0.08
Notes: dv =dependent variable. Collab refers to R&D collaboration. Persistent R&D collaboration is ongoing involvement in R&D collaboration of the same 
partner type. There is no correlation between new R&D collaboration with a partner type and prior (persistent or recent) R&D collaboration with the same 
partner type as this combination cannot occur. Correlations report on a sample of 26608 observations 
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Table 3. Antecedents of the establishment of R&D collaboration with new partner types: results of a 
multivariate probit model  
 
(1) 
Supplier R&D 
collaboration 
(2) 
Customer 
R&D 
collaboration 
(3) 
Competitor 
R&D 
collaboration 
(4) 
Institutional 
R&D 
collaboration 
Recent supplier            0.567***  0.313**   0.567*** 
                       (0.121)    (0.133)    (0.091)    
Persistent supplier            0.504***  0.087     0.315*** 
                       (0.103)    (0.109)    (0.085)    
Discontinued supplier  0.704***  0.118     0.114     0.204**  
             (0.079)    (0.131)    (0.137)    (0.093)    
Recent customer  0.569***            0.414**   0.440*** 
             (0.201)              (0.175)    (0.171)    
Persistent customer  0.331*              0.391**   0.377**  
             (0.193)              (0.155)    (0.152)    
Discontinued customer -0.140     0.802***  0.281    -0.130    
             (0.171)    (0.146)    (0.185)    (0.184)    
Recent competitor  0.069    -0.115               0.298    
             (0.206)    (0.251)              (0.208)    
Persistent competitor -0.021    -0.168              -0.034    
             (0.275)    (0.181)              (0.237)    
Discontinued competitor  0.262*    0.311*    0.609***  0.263*   
             (0.152)    (0.181)    (0.135)    (0.159)    
Recent institutional  0.625***  0.117     0.335**            
             (0.092)    (0.128)    (0.133)              
Persistent institutional  0.533***  0.243**   0.363***           
             (0.081)    (0.107)    (0.102)              
Discontinued institutional  0.100     0.008     0.089     0.608*** 
             (0.091)    (0.145)    (0.162)    (0.076)    
Innovation Performance  0.040**   0.033     0.068***  0.030*   
             (0.017)    (0.027)    (0.026)    (0.017)    
Innovation Performance SQ  0.003     0.007    -0.016*   -0.004    
             (0.006)    (0.008)    (0.009)    (0.006)    
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Table 3 continued 
 
Firm size     0.169***  0.145***  0.071**   0.102*** 
             (0.018)    (0.028)    (0.030)    (0.017)    
R&D intensity  1.515***  1.959***  0.043     1.606*** 
             (0.275)    (0.419)    (0.513)    (0.269)    
Export intensity  0.002**   0.006***  0.006***  0.002*   
             (0.001)    (0.001)    (0.001)    (0.001)    
Constraints on resources -0.020*   -0.043**  -0.011    -0.002    
             (0.011)    (0.018)    (0.018)    (0.010)    
Patents/R&D  -0.053    -0.129    -1.139**  -0.131    
             (0.104)    (0.134)    (0.546)    (0.167)    
Patent dummy  0.150***  0.275***  0.232***  0.170*** 
             (0.050)    (0.067)    (0.076)    (0.050)    
‘R’ to ‘D’ expenditures ratio  0.082*    0.003     0.028     0.108**  
             (0.047)    (0.079)    (0.073)    (0.044)    
Inverse Mill’s ratio  -1.178*** -0.877    -1.677*** -1.052*** 
             (0.275)    (0.534)    (0.534)    (0.233)    
Constant     -2.620*** -3.667*** -2.402*** -2.145*** 
             (0.327)    (0.474)    (0.522)    (0.260)    
     
Correlation coefficients     
 Rho1 Rho2 Rho3  
Rho/2 0.728*** 
(0.066) 
   
Rho/3  0.558*** 
(0.038) 
0.692*** 
(0.038) 
  
Rho/4 0.767*** 
(0.017) 
0.606*** 
(0.037) 
0.679*** 
(0.032) 
 
     
Model fit statistics     
ROC (area under the curve) 0.82 0.88 0.83 0.50 
McFadden R2  0.161     0.217     0.160     0.126    
Log-likelihood (full model) -5872.55                                  
Log-likelihood (constant only) -6839.37    
LR ߯ଶሺ168ሻa 
 
1933.65***     
LR ߯ଶሺ6ሻb 
 
2891.91***     
Wald  ߯ଶ (172) model 
significance)         1904.13***                                  
Notes: 18 industry and 5-year dummies are included. Robust (clustered) standard errors in parentheses. Mc Fadden 
statistics are based on re-estimation of the model as separate probit models. Persistent R&D collaboration is ongoing 
involvement in R&D collaboration of the same partner type. 
* Significant at 10%;  **   Significant at 5%;  *** Significant at 1%.  
a Likelihood-ratio test between the constant-only model and the full model. 
b Likelihood-ratio test of all correlation coefficients rho=0. 
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